Besides, the downregulation of FXR by siRNA or its inhibition by its natural antagonist, guggulsterone, resulted in the suppression of NF-κB activity and its regulated target vascular endothelial growth factor (VEGF), which lead to decreased cell proliferation, invasion and migration of pancreatic cancer cells. This evidence concerns the gene NFKB1 and familial pancreatic carcinoma.